Improvement in antipsychotic-induced hyperprolactinemia with the addition of aripiprazole in schizophrenic patients
نویسندگان
چکیده
منابع مشابه
Reversal of symptomatic antipsychotic-induced hyperprolactinemia with addition of aripiprazole
Reversal of symptomatic antipsychotic-induced hyperprolactinemia with addition of aripiprazole Paraskevi Kotorki, Parthena Pelka, Christina Leotsakou, Aikaterini Kalogeropoulou, Markella Fiste, Georgios Vagionis, Anastasia Roussi, Periklis Paterakis From 1 International Congress on Neurobiology and Clinical Psychopharmacology and European Psychiatric Association Conference on Treatment Guidance...
متن کاملAttenuation of risperidone-induced hyperprolactinemia with the addition of aripiprazole.
Hyperprolactinemia can be a complication of conventional neurolepics as well as risperidone. We report the third case of attenuation of risperidone-induced hyperprolactinemia by aripiprazole.
متن کاملPM403. Comparison between addition of and switching to aripiprazole for resolving antipsychotic-induced hyperprolactinemia
s | 47 scores. A linear regression analysis revealed that being male and married had significant positive associations with sexual arousal, sexual satisfaction, and/or sexual desire, while the presence of TD and a longer duration of illness were associated with poor sexual arousal and/or sexual desire. Additionally, sexual function was significantly associated with SWN-K and DAI scores in mult...
متن کاملAripiprazole reverses paliperidone-induced hyperprolactinemia.
Hyperprolactinemia is a common side effect of antipsychotic treatments. Existing alternatives to resolve this problem include decreasing the antipsychotic dose or switching to a different antipsychotic agent. Nevertheless, said modifications can sometimes lead to decompensation of the patient. We report a clinical case of a female patient in whom the combined treatment of 5 mg/day of aripiprazo...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Clinical Neuropsychopharmacology and Therapeutics
سال: 2010
ISSN: 1884-8826
DOI: 10.5234/cnpt.1.1